These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 32770836)

  • 1. Immune-Mobilizing Monoclonal T Cell Receptors Mediate Specific and Rapid Elimination of Hepatitis B-Infected Cells.
    Fergusson JR; Wallace Z; Connolly MM; Woon AP; Suckling RJ; Hine DW; Barber C; Bunjobpol W; Choi BS; Crespillo S; Dembek M; Dieckmann N; Donoso J; Godinho LF; Grant T; Howe D; McCully ML; Perot C; Sarkar A; Seifert FU; Singh PK; Stegmann KA; Turner B; Verma A; Walker A; Leonard S; Maini MK; Wiederhold K; Dorrell L; Simmons R; Knox A
    Hepatology; 2020 Nov; 72(5):1528-1540. PubMed ID: 32770836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineering virus-specific T cells that target HBV infected hepatocytes and hepatocellular carcinoma cell lines.
    Gehring AJ; Xue SA; Ho ZZ; Teoh D; Ruedl C; Chia A; Koh S; Lim SG; Maini MK; Stauss H; Bertoletti A
    J Hepatol; 2011 Jul; 55(1):103-10. PubMed ID: 21145860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TCR-like bispecific antibodies toward eliminating infected hepatocytes in HBV mouse models.
    Shi Y; Wang Z; Xu J; Niu W; Wu Y; Guo H; Shi J; Li Z; Fu B; Hong Y; Wang Z; Guo W; Chen D; Li X; Li Q; Wang S; Gao J; Sun A; Xiao Y; Cao J; Fu L; Wu Y; Zhang T; Xia N; Yuan Q
    Emerg Microbes Infect; 2024 Dec; 13(1):2387448. PubMed ID: 39109538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T cells redirected against hepatitis B virus surface proteins eliminate infected hepatocytes.
    Bohne F; Chmielewski M; Ebert G; Wiegmann K; Kürschner T; Schulze A; Urban S; Krönke M; Abken H; Protzer U
    Gastroenterology; 2008 Jan; 134(1):239-47. PubMed ID: 18166356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery and Selection of Hepatitis B Virus-Derived T Cell Epitopes for Global Immunotherapy Based on Viral Indispensability, Conservation, and HLA-Binding Strength.
    de Beijer MTA; Jansen DTSL; Dou Y; van Esch WJE; Mok JY; Maas MJP; Brasser G; de Man RA; Woltman AM; Buschow SI
    J Virol; 2020 Mar; 94(7):. PubMed ID: 31852786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenoviral delivery of recombinant hepatitis B virus expressing foreign antigenic epitopes for immunotherapy of persistent viral infection.
    Wang Z; Zhu K; Bai W; Jia B; Hu H; Zhou D; Zhang X; Zhang X; Xie Y; Bourgine MM; Michel ML; Lan K; Deng Q
    J Virol; 2014 Mar; 88(5):3004-15. PubMed ID: 24371056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T cells expressing a chimeric antigen receptor that binds hepatitis B virus envelope proteins control virus replication in mice.
    Krebs K; Böttinger N; Huang LR; Chmielewski M; Arzberger S; Gasteiger G; Jäger C; Schmitt E; Bohne F; Aichler M; Uckert W; Abken H; Heikenwalder M; Knolle P; Protzer U
    Gastroenterology; 2013 Aug; 145(2):456-65. PubMed ID: 23639914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T-cell engager antibodies enable T cells to control HBV infection and to target HBsAg-positive hepatoma in mice.
    Quitt O; Luo S; Meyer M; Xie Z; Golsaz-Shirazi F; Loffredo-Verde E; Festag J; Bockmann JH; Zhao L; Stadler D; Chou WM; Tedjokusumo R; Wettengel JM; Ko C; Noeßner E; Bulbuc N; Shokri F; Lüttgau S; Heikenwälder M; Bohne F; Moldenhauer G; Momburg F; Protzer U
    J Hepatol; 2021 Nov; 75(5):1058-1071. PubMed ID: 34171437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonlytic Lymphocytes Engineered to Express Virus-Specific T-Cell Receptors Limit HBV Infection by Activating APOBEC3.
    Koh S; Kah J; Tham CYL; Yang N; Ceccarello E; Chia A; Chen M; Khakpoor A; Pavesi A; Tan AT; Dandri M; Bertoletti A
    Gastroenterology; 2018 Jul; 155(1):180-193.e6. PubMed ID: 29550589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Hepatitis B Surface Antigen on Virus-Specific and Global T Cells in Patients With Chronic Hepatitis B Virus infection.
    Le Bert N; Gill US; Hong M; Kunasegaran K; Tan DZM; Ahmad R; Cheng Y; Dutertre CA; Heinecke A; Rivino L; Tan A; Hansi NK; Zhang M; Xi S; Chong Y; Pflanz S; Newell EW; Kennedy PTF; Bertoletti A
    Gastroenterology; 2020 Aug; 159(2):652-664. PubMed ID: 32302614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spatiotemporal Differences in Presentation of CD8 T Cell Epitopes during Hepatitis B Virus Infection.
    Khakpoor A; Ni Y; Chen A; Ho ZZ; Oei V; Yang N; Giri R; Chow JX; Tan AT; Kennedy PT; Maini M; Urban S; Bertoletti A
    J Virol; 2019 Feb; 93(4):. PubMed ID: 30518652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recognition of Core- and Polymerase-derived immunogenic peptides included in novel therapeutic vaccine by T cells from Chinese chronic hepatitis B patients.
    Huang D; Sansas B; Jiang JH; Gong QM; Jin GD; Calais V; Yu DM; Zhu MY; Wei D; Zhang DH; Inchauspé G; Zhang XX; Zhu R
    J Viral Hepat; 2017 Nov; 24 Suppl 1():66-74. PubMed ID: 29082648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T cell receptor grafting allows virological control of Hepatitis B virus infection.
    Wisskirchen K; Kah J; Malo A; Asen T; Volz T; Allweiss L; Wettengel JM; Lütgehetmann M; Urban S; Bauer T; Dandri M; Protzer U
    J Clin Invest; 2019 Apr; 129(7):2932-2945. PubMed ID: 31039136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Detection of antigen-epitope-specific cytotoxic T lymphocytes in patients with hepatitis B virus infection by enzyme linked immunospot assay].
    Zhang HP; Yan HP; Zhang YH; Feng X; Zhao Y; Liao HY; Liu YM; Chen Y; Tan YF; Liu Y
    Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Aug; 43(8):690-4. PubMed ID: 20021848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation and functional characterization of hepatitis B virus-specific T-cell receptors as new tools for experimental and clinical use.
    Wisskirchen K; Metzger K; Schreiber S; Asen T; Weigand L; Dargel C; Witter K; Kieback E; Sprinzl MF; Uckert W; Schiemann M; Busch DH; Krackhardt AM; Protzer U
    PLoS One; 2017; 12(8):e0182936. PubMed ID: 28792537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defining virus-specific CD8+ TCR repertoires for therapeutic regeneration of T cells against chronic hepatitis E.
    Soon CF; Behrendt P; Todt D; Manns MP; Wedemeyer H; Sällberg Chen M; Cornberg M
    J Hepatol; 2019 Oct; 71(4):673-684. PubMed ID: 31203151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knockdown of Virus Antigen Expression Increases Therapeutic Vaccine Efficacy in High-Titer Hepatitis B Virus Carrier Mice.
    Michler T; Kosinska AD; Festag J; Bunse T; Su J; Ringelhan M; Imhof H; Grimm D; Steiger K; Mogler C; Heikenwalder M; Michel ML; Guzman CA; Milstein S; Sepp-Lorenzino L; Knolle P; Protzer U
    Gastroenterology; 2020 May; 158(6):1762-1775.e9. PubMed ID: 32001321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TLR7 Agonist Increases Responses of Hepatitis B Virus-Specific T Cells and Natural Killer Cells in Patients With Chronic Hepatitis B Treated With Nucleos(T)Ide Analogues.
    Boni C; Vecchi A; Rossi M; Laccabue D; Giuberti T; Alfieri A; Lampertico P; Grossi G; Facchetti F; Brunetto MR; Coco B; Cavallone D; Mangia A; Santoro R; Piazzolla V; Lau A; Gaggar A; Subramanian GM; Ferrari C
    Gastroenterology; 2018 May; 154(6):1764-1777.e7. PubMed ID: 29378197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activating adaptive immunity by bispecific, T-cell engager antibodies bridging infected and immune-effector cells is a promising novel therapy for chronic hepatitis B.
    Xie Z; Protzer U
    Antiviral Res; 2024 Sep; 229():105972. PubMed ID: 39084340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of cytotoxic T lymphocytes with peptides in vitro: identification of candidate T-cell epitopes in hepatitis B virus X antigen.
    Chung MK; Yoon H; Min SS; Lee HG; Kim YJ; Lee TG; Lim JS; Kim CM; Park SN
    J Immunother; 1999 Jul; 22(4):279-87. PubMed ID: 10404429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.